Discontinued — last reported Q3 '18
Illumina Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 23.1% to $40.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q3 '21 | Q2 '24 | Q3 '24 | Q1 '26 | |
|---|---|---|---|---|
| Value | $163.00M | $45.00M | $52.00M | $40.00M |
| QoQ Change | — | -72.4% | +15.6% | -23.1% |